KMT Pharm
Pharmacovigilance outsourcing for pharma companies: PSMF, literature monitoring, QPPV and local PV person services in Slovakia
Highlights
- Young companyFounded 2023
- ProfitableFY2025 net profit €2k · RÚZ
- New on EvolcAdded 2026-10-17
About KMT Pharm
KMT Pharm, s.r.o. provides pharmacovigilance services for marketing authorisation holders, including Pharmacovigilance System Master File (PSMF) preparation, PV training, monitoring of local medical literature, and preparation of PSUR and RMP documents.
The company offers EU Qualified Person Responsible for Pharmacovigilance (QPPV) services, Deputy QPPV support, and Local QPPV and Local PV Person services for Slovakia. Its clients are pharmaceutical companies that need to meet PV requirements when marketing medicinal products.
The company is registered in Slovakia, with Bratislava as its registered city, and was founded on 11 January 2023. The website does not list additional offices or markets beyond Slovakia.
Product: Outsourced pharmacovigilance services: PSMF, literature monitoring, PV training, PSUR/RMP preparation and QPPV/local PV person roles.
Financials
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue | €44k | €55k | €11k |
| Growth | −19% | +418% | — |
| EBITDA | €3k | −€818 | €2k |
| Operating profit | €3k | −€2k | €2k |
| Net profit | €2k | −€3k | €2k |
| Net margin | 4.8% | −4.7% | 16.7% |
| Personnel costs | €811 | €10k | €0 |
| Total assets | €10k | €15k | €9k |
| Cash | €4k | €3k | €2k |
| Liabilities | €3k | €11k | €2k |
| Equity | €6k | €4k | €7k |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Open jobs
Leadership
- Kristína Červenáková · Konateľ (Managing director)Source: business register
Tech stack
- Complianz
- Elementor
- WordPress
- jQuery